Medicare Open Enrollment Is Starting. Here’s How to Navigate the Ad Blitz.news2023-10-14T09:01:47+00:00October 14th, 2023|The New York Times|
The Disruptive Power of Weight Loss Drugs Is Being Felt Beyond Pharmanews2023-09-02T20:23:31+00:00September 2nd, 2023|The New York Times|
A Major Overhaul of Prescription Drug Pricesnews2023-08-31T15:25:51+00:00August 31st, 2023|The New York Times|
FDA Approves First Pill for Postpartum Depressionnews2023-08-05T03:39:10+00:00August 5th, 2023|The New York Times|
Patients Are Being Crushed by Health Care Bureaucracynews2023-07-20T09:00:06+00:00July 20th, 2023|The New York Times|
How the Birth Control Pill Got Over the Counternews2023-07-20T06:17:28+00:00July 20th, 2023|The New York Times|
Over-the-Counter Birth Control Pills Are Coming. What’s Next?news2023-07-19T09:00:27+00:00July 19th, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
Cancer Drug Advancements Give New Hope to Metastatic Patientsnews2023-06-16T19:26:50+00:00June 16th, 2023|The New York Times|
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risksnews2023-05-10T17:21:21+00:00May 10th, 2023|The New York Times|
